SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?


To: Joe Copia who wrote (8805)10/20/1998 12:35:00 PM
From: Gator  Respond to of 25711
 
CYPB (Nasdaq-Cypress Bioscience) starting to perk up. FDA review on Oct. 29. Should see volume and price movement pick up between now and then, with a potential spike on Oct 29 if arthritis device is approved. Tons of insider buying from Aries Fund.

Gator



To: Joe Copia who wrote (8805)10/20/1998 12:41:00 PM
From: LANCE B  Read Replies (1) | Respond to of 25711
 
inti and inni------ref new and old pick.....
just was going over your web site ....thought
i remembered you picking inni.......did you see
the news yesterday....company is really starting to
make some head way......profitable and at .15.....
ref new pick ,inti,bought several months ago at .19...
very nice pick,joe.......